Shopping Cart
- Remove All
- Your shopping cart is currently empty
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $240 | In Stock | |
5 mg | $600 | In Stock | |
10 mg | $855 | In Stock | |
25 mg | $1,280 | In Stock | |
50 mg | $1,750 | In Stock | |
100 mg | $2,360 | In Stock | |
500 mg | $4,730 | In Stock |
Description | Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp. |
Targets&IC50 | RNA synthesis and primer extension:4~5 nM |
In vivo | Setrobuvir (200, 400, and 800 mg) BID were -2.1, -2.2, and -2.9 log10 IU/mL, respectively (vs ≤0.1 log10 IU/mL with placebo).[3] |
Alias | RO-5466731, RG-7790, RG7790, ANA-598, ANA598 |
Molecular Weight | 560.62 |
Formula | C25H25FN4O6S2 |
Cas No. | 1071517-39-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 5.61 mg/mL (10 mM) | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.